Chemnitz, Germany, March 13, 2018—3D-Micromac AG, a leading supplier of laser micromachining and roll-to-roll laser systems for the photovoltaic, medical device and electronics markets, today unveiled its Clean Scribe technology, a new patent-pending feature for its microDICE™ laser micromachining system that enables particle-free scribing of silicon carbide (SiC) wafers without the need for expensive coatings and without impacting wafer dicing throughput.

3D-Micromac‘s microMARK MCF RXe200 is a premium quality marking device for all kinds of blocked lenses. Equipped with an Excimer laser including an optimized optical components setup and a large-sized magnification ratio this new generation of RX marking devices offers an increased depth of focus at lowest laser power operation on all materials.

The supervisory board of 3D-Micromac AG has appointed Uwe Wagner to the board of directors. Since October 1, 2017, he has been supporting Tino Petsch, the only member of the board to date. Uwe Wagner now is responsible for the technological and commercial management of the German laser specialist.

Chemnitz, September 7, 2017: The Chemnitz-based mechanical engineering company 3D-Micromac AG, the leading specialist in laser micro-processing, will be celebrating its 15th year of existence on September 7, 2017. At the same time, 3D-Micromac will be opening the newly constructed main building on the Chemnitz Smart Systems Campus with a ceremonial event for customers, business partners and employees. In addition to the anniversary and inauguration ceremony in the evening, the company will be welcoming laser experts at the in-house trade fair ILaCoS during the day, which as usual will offer expert lectures and workshops dealing with current topics in laser micro-processing.

Allotex Inc., an ophthalmic biologics and device company developing therapeutic solutions to treat presbyopia, hyperopia and myopia, and 3D-Micromac, a leading supplier of laser micromachining systems for the photovoltaic, electronics and medical device markets, today announced they have entered into a master cooperative agreement. The two companies will work together to develop and market a laser system for precisely shaping human corneal allografts used to create natural lenses which can be administered in an outpatient visit.